Skip to main content
EJNMMI Physics

Table 6 Binary logistic regression analyses between cumulative TADs and target lesion response based on RECIST-L criteria

From: Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour

Dependent variable

Independent variable

Odds ratio [confidence interval]

p

Disease control (RECIST-L)

Cumulative TADmax

1.031 [1.004, 1.059]

0.024*

Cumulative TADpeak

1.034 [1.004, 1.066]

0.025*

Cumulative TAD41

1.051 [1.006, 1.098]

0.026*

  1. TAD: tumour-absorbed dose
  2. Cumulative TAD: sum of the tumour-absorbed doses from all PRRT cycles
  3. *p < 0.05
Back to article page